Tower Research Capital LLC (TRC) - TRANSCEPT PHARMACEUTICALS IN ownership

TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 46 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$16,000
+700.0%
8,072
+691.4%
0.00%
Q2 2014$2,000
-50.0%
1,020
-25.5%
0.00%
-100.0%
Q1 2014$4,000
-33.3%
1,370
-22.4%
0.00%0.0%
Q4 2013$6,000
-45.5%
1,765
-48.2%
0.00%0.0%
Q3 2013$11,000
-38.9%
3,408
-41.3%
0.00%0.0%
Q2 2013$18,0005,8010.00%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q2 2013
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,031,874$6,258,0006.29%
NEA Management Company, LLC 2,086,755$6,427,0000.32%
BVF INC/IL 150,000$462,0000.07%
Central Square Management LLC 19,000$59,0000.06%
ABNER HERRMAN & BROCK LLC 20,000$62,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 137,000$422,0000.01%
SHEPHERD KAPLAN KROCHUK, LLC 31,000$95,0000.01%
Spark Investment Management LLC 11,100$34,0000.01%
Waverly Advisors, LLC 2,670$8,0000.00%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 33,384$103,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders